Autonomix Medical Common Stock Today
| AMIX Stock | 0.54 0.01 1.82% |
PerformanceWeakest
| Odds Of DistressRisky
|
Autonomix Medical is trading at 0.54 as of the 2nd of January 2026; that is 1.82 percent decrease since the beginning of the trading day. The stock's open price was 0.55. Autonomix Medical has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 11th of July 2024 and ending today, the 2nd of January 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 29th of January 2024 | Category Healthcare | Classification Health Care |
Autonomix Medical is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 6.91 M outstanding shares of which 133.86 K shares are presently shorted by private and institutional investors with about 0.01 trading days to cover. More on Autonomix Medical Common
Moving together with Autonomix Stock
Moving against Autonomix Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Autonomix Stock Highlights
| CEO President | Bradley Hauser | |||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
Debt LevelsAutonomix Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Autonomix Medical's financial leverage. It provides some insight into what part of Autonomix Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||
Autonomix Medical Common (AMIX) is traded on NASDAQ Exchange in USA and employs 8 people. Autonomix Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.8 M. Autonomix Medical Common conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 6.91 M outstanding shares of which 133.86 K shares are presently shorted by private and institutional investors with about 0.01 trading days to cover.
Autonomix Medical generates negative cash flow from operations
Check Autonomix Medical Probability Of Bankruptcy
Ownership AllocationAutonomix Medical Common shows 6.71 percent of its outstanding shares held by insiders and 4.77 percent owned by other corporate entities.
Check Autonomix Ownership Details
Autonomix Medical Historical Income Statement
Autonomix Stock Against Markets
Autonomix Medical Corporate Executives
Elected by the shareholders, the Autonomix Medical's board of directors comprises two types of representatives: Autonomix Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Autonomix. The board's role is to monitor Autonomix Medical's management team and ensure that shareholders' interests are well served. Autonomix Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Autonomix Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert MD | CoFounder Officer | Profile | |
| Landy Toth | CoFounder Officer | Profile |
Already Invested in Autonomix Medical Common?
The danger of trading Autonomix Medical Common is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Autonomix Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Autonomix Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Autonomix Medical Common is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.